Ann: Imugene Corporate Presentation, page-224

I went along to the lunch in Melbourne on Friday and not one question was about the share price and no one gave LC or YF a hard time actual all praise.

The best question was left until last and it was asked over the other side of the room so I couldn't hear clearly so don't quote me on this. It was something like at what stage in the Vaxinia trial do you start talking to the FDA about fast-tracking. LC and YF both said something along the lines of we are or have already had discussions. They also said something like the FDA said they can only present one group of patients that have one cancer type, seeing that Vaxina has something like 10 different types they need to work out which group they will present. As well as that I think they said they need a sample size of around 12-14 people. I left thinking wow if LC and YF ( with their collective experience ) have the confidence to be talking to the FDA now then we have something special!